Iguratimod can significantly decrease the TNF-α concentration.21,26 During iguratimod clinical trials, the synovium of RA patients showed decreased production of colony-stimulating factor, IL-6, and IL-8. This evidence concerns the gene CXCL8 and rheumatoid arthritis.